Aiviva biopharma

Index
Globenewswire

AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by Intradermal Injection for Nonmelanoma Skin Cancer

Globenewswire

AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema

Globenewswire

AiViva Biopharma Appoints Lester J. Kaplan, PhD to the Board of Directors